Forge 2025.3 adds AI Assistant to SQL Complete, supports SSMS 22, Visual Studio 2026, MySQL 9.5, MariaDB 12.2, and ...
Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results